This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of pharmaceutical products, specifically IPOL VIAL 5ML. The contract has a ceiling value of $1,067.35 and a total performance period through August 13, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by defense and civilian agencies...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $43,892.31 and covers the delivery of IPOL VIAL 5ML medical products. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,281.46, is for the delivery of 4558099326 IPOL VIAL 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 16, 2022. AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award Management...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,808.20 firm fixed price contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a completion date of November 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,694.00, is for the procurement of IPOL VIAL 5ML medical products. This is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of May 29, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4564628204 IPOL VIAL 5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $10,673.50, and an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for IPOL VIAL 5ML medical supplies. The $18,635.60 firm fixed-price contract has an ultimate completion date of May 9, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,134.70. The contract has an ultimate completion date of October 7, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML medical products. The $1,796.20 contract has an ultimate completion date of August 23, 2022. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IPOL VIAL 5ML products. The contract has a ceiling value of $16,437.19 and a completion date of August 21, 2024. It is a firm fixed-price contract and does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, is the prime contractor for this award. The company has a broad range of federal...